Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Caër, Charles ^a,b,c   Rouault, Christine ^a,b,c   Le Roy, Tiphaine ^a,b,c   Poitou, Christine ^a,b,c,d   Aron Wisnewsky, Judith ^a,b,c,d   Torcivia, Adriana ^d   Bichet, Jean Christophe ^d   Clément, Karine ^a,b,c,d   Guerre Millo, Michèle ^a,b,c   André, Sébastien ^a,b,c  

^a Sorbonne Universités   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADIPOCYTE; ADIPOSE TISSUE; CELL CULTURE; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY;

EID: 85020394098     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02660-w     Document Type: Article

References (43)

1. DiSpirito, J. R. & Mathis, D. Immunological contributions to adipose tissue homeostasis. Semin Immunol 27, 315-21 (2015).
2. Morris, D. L., Singer, K. & Lumeng, C. N. Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. Curr Opin Clin Nutr Metab Care 14, 341-6 (2011).
3. Chawla, A., Nguyen, K. D. & Goh, Y. P. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 11, 738-49 (2011).
4. Dalmas, E., Clement, K. & Guerre-Millo, M. Defining macrophage phenotype and function in adipose tissue. Trends Immunol 32, 307-14 (2011).
5. Kratz, M. et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab 20, 614-25 (2014).
6. Suganami, T., Nishida, J. & Ogawa, Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25, 2062-8 (2005).
7. Permana, P. A., Menge, C. & Reaven, P. D. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem. Biophys. Res Commun. 341, 507-514 (2006).
8. Lumeng, C. N., Deyoung, S. M. & Saltiel, A. R. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 292, E166-74 (2007).
9. Lacasa, D., Taleb, S., Keophiphath, M., Miranville, A. & Clement, K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148, 868-877 (2007).
10. Keophiphath, M. et al. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 23, 11-24 (2009).
11. O'Hara, A., Lim, F. L., Mazzatti, D. J. & Trayhurn, P. Stimulation of inflammatory gene expression in human preadipocytes by macrophage-conditioned medium: upregulation of IL-6 production by macrophage-derived IL-1beta. Mol Cell Endocrinol 349, 239-47 (2012).
12. Gao, D. et al. Interleukin-1beta mediates macrophage-induced impairment of insulin signaling in human primary adipocytes. Am J Physiol Endocrinol Metab 307, E289-304 (2014).
13. Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance. Science 259, 87-91 (1993).
14. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-7 (2006).
15. Osborn, O. et al. Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine 44, 141-8 (2008).
16. McGillicuddy, F. C. et al. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 60, 1688-98 (2011).
17. Cavelti-Weder, C. et al. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35, 1654-62 (2012).
18. Lagathu, C. et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 311, 372-9 (2003).
19. Rotter, V., Nagaev, I. & Smith, U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278, 45777-84 (2003).
20. Bastard, J. P. et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338-42 (2000).
21. Bastard, J. P. et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87, 2084-9 (2002).
22. Bourlier, V. et al. TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages. PLoS One 7, e31274 (2012).
23. Bertola, A. et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 61, 2238-47 (2012).
24. Fabbrini, E. et al. Association Between Specific Adipose Tissue CD4(+) T-Cell Populations and Insulin Resistance in Obese Individuals. Gastroenterology 145(366-374), e3 (2013).
25. Dalmas, E. et al. T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 63, 1966-77 (2014).
26. Lagathu, C. et al. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49, 2162-73 (2006).
27. Jager, J., Gremeaux, T., Cormont, M., Le Marchand-Brustel, Y. & Tanti, J. F. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148, 241-51 (2007).
28. Wang, Z. et al. High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22. PLoS One 6, e23737 (2011).
29. Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237-41 (2014).
30. Zuniga, L. A. et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol 185, 6947-59 (2010).
31. Ahmed, M. & Gaffen, S. L. IL-17 inhibits adipogenesis in part via C/EBPalpha, PPARgamma and Kruppel-like factors. Cytokine 61, 898-905 (2013).
32. Rouault, C. et al. Roles of chemokine ligand-2 (CXCL2) and neutrophils in influencing endothelial cell function and inflammation of human adipose tissue. Endocrinology 154, 1069-79 (2013).
33. Pellegrinelli, V., Rouault, C., Veyrie, N., Clement, K. & Lacasa, D. Endothelial cells from visceral adipose tissue disrupt adipocyte functions in a three-dimensional setting: partial rescue by angiopoietin-1. Diabetes 63, 535-49 (2014).
34. Reggio, S. et al. Increased basement membrane components in adipose tissue during obesity: links with TGFbeta and metabolic phenotypes. J Clin Endocrinol Metab, jc20154304 (2016).
35. Dinarello, C. A., Marnoy, S. O. & Rosenwasser, L. J. Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1. J Immunol 130, 890-5 (1983).
36. Weber, A., Wasiliew, P. & Kracht, M. Interleukin-1beta (IL-1beta) processing pathway. Sci Signal 3, cm2 (2010).
37. Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013-22 (2014).
38. Guo, H., Callaway, J. B. & Ting, J. P. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21, 677-87 (2015).
39. Cho, K. A., Suh, J. W., Lee, K. H., Kang, J. L. & Woo, S. Y. IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1beta by keratinocytes via the ROS-NLRP3-caspase-1 pathway. Int Immunol 24, 147-58 (2012).
40. Divoux, A. et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 59, 2817-25 (2010).
41. Wilson, M. S. et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207, 535-52 (2010).
42. Mi, S. et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol 187, 3003-14 (2011).
43. Tohyama, M. et al. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression. Eur J Immunol 39, 2779-88 (2009).